GABA/baclofen stabilizes PD-L1 and enhances immunotherapy of breast cancer
The programmed death-ligand 1 (PD-L1) on the surface of tumor cells binds to the receptor programmed cell death protein 1 (PD-1) on effector T cells, thereby inhibiting the anti-tumor immune response. Immune checkpoint blockade (ICB) therapy targeting PD-1/PD-L1 has been approved for the treatment o...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2024-04-01
|
| סדרה: | Heliyon |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2405844024046310 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|